Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 80 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K08NS092912
National Institutes of Health
Grant: R01NS112712
National Institutes of Health
Grant: R01CA178844
NCI NIH HHS
Grant: F30 CA236454
NIAID NIH HHS
Grant: T32 AI007163
National Institutes of Health
Grant: 5R01NS112712-02
Targeting Neoantigens in Glioblastoma
National Institutes of Health
Grant: 5R01CA178844-04
Engineering T Cell Receptors for Adoptive Cell Therapies
National Institutes of Health
Grant: 1K08NS092912-01
IMMUNOBIOLOGY OF MALIGNANT GLIOMA
Howard Hughes Medical Institute
Damon Runyon Cancer Research Foundation
FWCI
5.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals